BX Swiss TOP 30 CHF
1.269,64
PKT
-13,94
PKT
-1,09
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
21.04.22 | UBS Underweight | Barclays Capital | |
21.04.22 | UBS Equal Weight | Barclays Capital | |
21.04.22 | UBS Neutral | UBS AG | |
21.04.22 | Nestlé Buy | UBS AG | |
21.04.22 | Nestlé Sector Perform | RBC Capital Markets | |
21.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
21.04.22 | Nestlé Underperform | Jefferies & Company Inc. | |
20.04.22 | Swiss Re Overweight | Barclays Capital | |
20.04.22 | UBS Hold | Jefferies & Company Inc. | |
20.04.22 | UBS Sector Perform | RBC Capital Markets | |
20.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
19.04.22 | Roche Buy | Jefferies & Company Inc. | |
19.04.22 | Novartis Buy | Jefferies & Company Inc. | |
19.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
19.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
19.04.22 | Nestlé Overweight | JP Morgan Chase & Co. | |
19.04.22 | Roche Sell | UBS AG | |
19.04.22 | Holcim Equal Weight | Barclays Capital | |
14.04.22 | Holcim Outperform | Credit Suisse Group | |
14.04.22 | Holcim Neutral | JP Morgan Chase & Co. | |
14.04.22 | UBS Hold | Deutsche Bank AG | |
14.04.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
13.04.22 | UBS Neutral | UBS AG | |
13.04.22 | Givaudan Neutral | UBS AG | |
13.04.22 | Givaudan Hold | Deutsche Bank AG | |
13.04.22 | Roche Equal-weight | Morgan Stanley | |
13.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
13.04.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
13.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
12.04.22 | Givaudan Underweight | Barclays Capital | |
12.04.22 | Givaudan Add | Baader Bank | |
12.04.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
12.04.22 | Roche Neutral | JP Morgan Chase & Co. | |
12.04.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
12.04.22 | Givaudan Underperform | Jefferies & Company Inc. | |
11.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
11.04.22 | Richemont Outperform | RBC Capital Markets | |
11.04.22 | Richemont Buy | Jefferies & Company Inc. |